特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国の感染症ポイントオブケア検査 (POCT) 市場:2022年までの予測

US Point-of-Care Testing Infectious Disease Market, Forecast to 2022

発行 Frost & Sullivan 商品コード 731210
出版日 ページ情報 英文 56 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.61円で換算しております。
米国の感染症ポイントオブケア検査 (POCT) 市場:2022年までの予測 US Point-of-Care Testing Infectious Disease Market, Forecast to 2022
出版日: 2018年10月05日 ページ情報: 英文 56 Pages
概要

感染症の管理は医療従事者にとって未だ大きな課題となっています。ポイントオブケア診断検査(POCT)は、感染症を迅速に特定し、特にリソースの限られた施設での疾患管理を改善するための有用な情報を提供できると考えられています。

当レポートでは、米国の感染症ポイントオブケア検査市場について調査し、市場の現状と今後の展望、収益予測、成長の機会などをまとめています。

エグゼクティブサマリー

市場概要

  • 市場の背景と概要
  • POCTの償還

競合プレイブック

  • 競合ポートフォリオが注目する分野:感染症
  • 主な合併、買収、提携評価
  • 注目企業

促進因子と阻害因子

  • 主な市場促進因子
  • 市場阻害因子

収益予測分析

  • 予測の仮定
  • 収益予測
  • 技術別内訳
  • 大手競合の市場シェア
  • 感染症セグメント

展望シナリオ

  • 展望シナリオ
  • 主な技術動向
  • 将来の技術動向

成長の機会

  • 設計のシンプルさ、小型化、高精度
  • 敗血症、肝炎、新型インフルエンザ用のポイントオブケア検査の成長の機会
  • 成長の機会マトリクス
  • 戦略的動向

最後に

付録

Frost & Sullivanストーリー

目次
Product Code: 9AB9/A9

CLIA Waived Molecular POCT, Coupled with Upcoming Diseases Like Sepsis, Lyme Disease, New Strains of Influenza-H1, H3, and H7, will Drive Growth

Management of infectious diseases remains a critical challenge for public health professionals who face increasing demand to control the spread of existing and novel diseases. To provide appropriate healthcare assistance, it is imperative to diagnose the exact form of infection from an array of complicated symptoms expressed by the host. As the outcome of diagnosis is time-bound, the test accuracy-sensitivity and specificity-plays a key role in determining the disease type, which is vital for delivering enhanced patient care and represents a major challenge. Point-of-care diagnostic testing (POCT) has the potential to rapidly identify the infectious diseases and provide actionable information to improve disease management, especially in resource-limited settings.

The current challenges faced by the industry include efficiency of test accuracy, requirement for additional confirmatory test in laboratory, improper handling of patient samples, which may lead to errors and reimbursement cuts by Medicare and Medicaid. However, drivers such as technological innovation, expansion of CLIA-waived simple tests, and funding from research organization and NGOs have provided a strong impetus to the growth of the POCT market. With the synergistic effect of advanced technologies, such as chip-based PCR technique, fluid-phase immunoprecipitation assays, new multiplexing ecosystems, and smartphone-based POCT, the growth is anticipated to increase rapidly in the next 5 years.

Research Scope:

The key objective of this growth insight for infectious disease POCT study is to highlight the current market dynamics such as key market participants, market segments, and evolving business opportunities. The study aims to identify enterprises that are capable of shaping the future through best practices implementation, visionary leadership, and innovation in product offerings. Further, the study provides an analysis of market sizing by revenue and insights into key technological segments and disease areas. It covers the key drivers, challenges in the market impeding growth, competitive landscape, market participant strategies, and future growth strategies.

Research Highlights:

The study also highlights growth opportunities, key trends, mergers and acquisitions, notable partnerships, collaboration opportunities, and key companies to watch. The study is focused on the United States. Major participants mentioned in the study are Abbott, Quidel, Meridian, OraSure, Roche, GenMark, and Cepheid.

Key Issues Addressed:

  • What are the biggest opportunities for companies in the infectious disease point of care testing space?
  • What are the key factors that would drive the market and how will the segments evolve or change?
  • What are the total market size and the projected growth of POCT solutions for infectious diseases?
  • What are the emerging technological building blocks contributing to the future functionality of POCTs?
  • Which areas of POCT should category leaders consider for future growth and expansion?

Table of Contents

1. US POINT-OF-CARE TESTING INFECTIOUS DISEASE MARKET, FORECAST TO 2022

Executive Summary

  • Key Findings
  • Scope and Segmentation
  • Key Questions Addressed in this Study
  • Big Market Themes
  • Future Trends-Three Big Predictions

Market Overview

  • Market Background and Overview
  • Market Background and Overview (continued)
  • POCT Reimbursement

Competitive Playbook

  • Competitor Portfolio Focus Area-Infectious Disease
  • Key Mergers, Acquisitions, and Partnership Assessment
  • Key Companies to Watch

Drivers and Restraints

  • Key Market Drivers
  • Market Restraints

Revenue Forecast Analysis

  • Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Breakdown by Technology
  • Market Share by Top Competitors
  • Key Infectious Disease Segments
  • Key Infectious Disease Segments (continued)

Visioning Scenarios

  • Visioning Scenarios for the Infectious Disease POCT Market
  • Key Technology Trends in Infectious Disease POCT
  • Future Technology Trends in Infectious Disease POCT

Growth Opportunities

  • Growth Opportunity 1-Design Simplicity, Miniaturized and High Accuracy of Molecular Point of Care Tests to Provide Growth Opportunity
  • Growth Opportunity 1-Design Simplicity, Miniaturized and High Accuracy of Molecular Point of Care Tests to Provide Growth Opportunity (continued)
  • Growth Opportunity 2-Reemergence of Diseases Such as Sepsis, Hepatitis A and Incidence of New Forms of Influenza Such as H1, H3, and H7 Strains Would Provide Opportunity to Expand Product Pipeline
  • Growth Opportunity 3-Companies Expanding from Centralized to Decentralized CLIA-based Setting to Experience Growth Opportunity
  • Growth Opportunity Matrix
  • Strategic Imperatives for the Infectious Disease POCT Market

The Last Word

  • Future Trends-Three Big Predictions
  • Legal Disclaimer

Appendix

  • Competitive Product Matrix for Key Infectious Diseases
  • Competitive Product Matrix for Key Infectious Diseases (continued)
  • Competitive Product Matrix for Key Infectious Diseases (continued)
  • List of Exhibits

The Frost & Sullivan Story

  • The Frost & Sullivan Story
  • Value Proposition-Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360° Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy